Policy Advocacy in Action
Explore HLC’s policy documents that drive healthcare reform. From comment letters to federal agencies and Congressional testimony to coalition advocacy efforts, these materials demonstrate how we translate industry expertise into actionable policy recommendations that shape healthcare legislation.
HLC response to Senate Finance Committee Democrats’ RFI on Drug Pricing
HLC urged Congress to preserve incentives for continued biopharmaceutical innovation while pursuing solutions that improve affordability for beneficiaries. The letter raised concerns about proposals to expand Medicare drug price negotiation and impo…
HLC comments support strengthening intellectual property provisions of USMACA
The Healthcare Leadership Council (HLC) urges the U.S. Trade Representative to strengthen and restore intellectual property protections—especially for biopharmaceuticals—in the USMCA during its Joint Review, arguing this will boost innovation, inves…
HLC response to the Federal Trade Commission’s RFI regarding noncompete agreements
HLC argues for a balanced, narrowly tailored use of noncompete agreements in healthcare—supporting worker mobility and fair competition while preserving patient access, continuity of care, and incentives for organizational investment.
HLC response to the HHS/FTC/DOJ request for information regarding consolidation and the role of private equity in the healthcare sector
HLC argues that while competition is essential, consolidation, integration, and private capital investment also play critical roles in maintaining access, improving care, and supporting innovation in the U.S. healthcare system. They urge regulators …
HLC letter opposing Nevada’s 1332 waiver application to implement a state “public option”
HLC joint letter to NIST urging them to withdraw the proposed guidance on March-in rights.
HLC letter to The National Institute of Standards and Technology (NIST) criticizing the newly published guidance, “Draft Interagency March-In Framework.”
HLC joint letter to the Department of Commerce requesting an extension to the comment period of the request for information on an interagency march-in rights guidance framework
HLC joint letter urging Congress to pass legislation to fix the disparity in the IRA that subjects small molecule medicines to price setting sooner than biologics
HLC joint letter in support of H.R. 3799, the CHOICE Arrangement Act in advance of the House floor vote
HLC joint letter to House W&M and Education & Workforce committees in support of affordable health coverage for employees of small businesses
HLC letter in advance of House Education and the Workforce hearing, “Competition and Transparency: The Pathway Forward for A Stronger Health Care Market.”
Explore Our Policy Agenda
With a unified voice spanning the entire healthcare continuum, HLC is driving meaningful policy change to enhance the future of the U.S. healthcare system.
